Cargando…
Clinical evidence for synergy between immunotherapy and radiotherapy (SITAR)
Previous preclinical and clinical trials have shown promising antitumour activity and toxicity profile when employing the ‘Synergy between Immunotherapy and Radiotherapy’ (SITAR) strategy. Approximately, one in seven radiation therapy studies currently recruiting is investigating SITAR. This article...
Autores principales: | Gill, Suki, Nowak, Anna K, Bowyer, Samantha, Endersby, Raelene, Ebert, Martin A, Cook, Alistair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543060/ https://www.ncbi.nlm.nih.gov/pubmed/35699321 http://dx.doi.org/10.1111/1754-9485.13441 |
Ejemplares similares
-
RONC-02. MEASURING THE EFFECT OF CLINICALLY-RELEVANT RADIOTHERAPY PROTOCOLS ON THE JUVENILE MOUSE BRAIN
por: Buck, Jessica, et al.
Publicado: (2020) -
Enhancing the efficacy of immunotherapy using radiotherapy
por: Keam, Synat, et al.
Publicado: (2020) -
RONC-07. Fractionated radiotherapy is required to accurately mimic neurostructural late effects in preclinical models
por: Whitehouse, Jacqueline, et al.
Publicado: (2022) -
Nepal sitar
Publicado: (1986) -
Lyrical sitar
Publicado: (1991)